(CAH) Cardinal Health - Ratings and Ratios

Cardinal Health, Inc. (NYSE:CAH) is a leading healthcare services and products company with a global footprint spanning the United States, Canada, Europe, Asia, and other international markets. The company serves a diverse range of healthcare providers, including hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and home care patients. Its business is organized into two primary segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.

The Pharmaceutical and Specialty Solutions segment focuses on distributing branded, generic, and specialty pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also provides specialized services to pharmaceutical manufacturers and healthcare providers, such as pharmacy management services for hospitals and repackaging of generic pharmaceuticals and over-the-counter products. This segment is critical for ensuring that healthcare providers have access to the medications and supplies they need to deliver patient care.

The Global Medical Products and Distribution segment manufactures and distributes a wide array of medical, surgical, and laboratory products under the Cardinal Health brand. These include exam and surgical gloves, sharps disposal systems, wound care products, surgical drapes, gowns, and fluid suction systems. The company also distributes national brand products and provides supply chain services to healthcare providers, including the assembly and sale of sterile and non-sterile procedure kits.

Cardinal Health plays a vital role in optimizing the healthcare supply chain through its integrated technology solutions, which enhance efficiency and reduce costs for healthcare providers. The company also manufactures, prepares, and distributes radiopharmaceuticals and related treatments, further diversifying its offerings in the healthcare sector.

From a financial perspective, Cardinal Health has a market capitalization of approximately $30.77 billion, making it a large-cap company. Its trailing P/E ratio of 23.63 and forward P/E of 16.05 suggest that investors are pricing in expectations of future earnings growth. The company’s price-to-book (P/B) ratio of 16.07 indicates a premium valuation relative to its book value, which could reflect its strong market position and intangible assets. The price-to-sales (P/S) ratio of 0.14 highlights its ability to generate revenue relative to its market value.

Headquartered in Dublin, Ohio, Cardinal Health was founded in 1979 and has established itself as a trusted partner in the healthcare industry. Its extensive distribution network, diversified product portfolio, and commitment to supply chain optimization make it a key player in ensuring the delivery of healthcare services worldwide. For investors and fund managers, Cardinal Health’s stability, market reach, and role in the essential healthcare supply chain make it a company worth close consideration.

Website: https://www.cardinalhealth.com